RKTG/PAQR3 exerts anti-proliferative effects on multiple cancer types through negatively modulating Ras/Raf/MEK/ERK and PI3K/AKT signaling pathways by sequestering the GC key players in these cascades, as previously described in this review. This evidence concerns the gene AKT1 and cancer.